{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T12:40:31Z","timestamp":1684845631015},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1157\/13128270","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T17:37:50Z","timestamp":1231263470000},"page":"546-551","source":"Crossref","is-referenced-by-count":6,"title":["Demanda y prescripci\u00f3n de la profilaxis postexposici\u00f3n no ocupacional al VIH en Espa\u00f1a (2001-2005)"],"prefix":"10.1016","volume":"26","author":[{"given":"Nuria","family":"Vives","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Almeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia A.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Campins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13128270_bb0010","first-page":"1","article-title":"Public Health Service Guidelines for management of Health Care Workers exposure to HIV and recommendations for Post Exposure Prophylaxis","volume":"47","author":"Centers for Disease Control and Prevention (United States)","year":"1998","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1157\/13128270_bb0015","first-page":"1","article-title":"Update U.S. Public Health Service Guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis","volume":"54","author":"Panlilio","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1157\/13128270_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9343(97)89442-9","article-title":"Candidate antiretroviral agents for use in post exposure prophylaxis","volume":"102","author":"Saag","year":"1997","journal-title":"Am J Med"},{"key":"10.1157\/13128270_bb0025","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of post inoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIV infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"10.1157\/13128270_bb0030","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1128\/JVI.74.20.9771-9775.2000","article-title":"Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2)","volume":"74","author":"Otten","year":"2000","journal-title":"J Virol"},{"key":"10.1157\/13128270_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(97)00059-4","article-title":"Animals studies of prophylaxis","volume":"102","author":"Black","year":"1997","journal-title":"Am J Med"},{"key":"10.1157\/13128270_bb0040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1157\/13128270_bb0045","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1157\/13128270_bb0050","unstructured":"Centro de Estudios Epidemiol\u00f3gicos sobre el Sida de Catalu\u00f1a (CEESCAT). Sistema integrado de vigilancia epidemiol\u00f3gica del VIH\/ITS en Catalu\u00f1a (SIVES). Informe anual. Barcelona: Generalitat de Catalu\u00f1a, Departamento de Salud; 2005."},{"key":"10.1157\/13128270_bb0055","first-page":"496","article-title":"Public Health Service Opening of nonoccupational HIV postexposure prophylaxis registry","volume":"48","author":"Centers for Disease Control and Prevention (United States)","year":"1999","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1157\/13128270_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1071\/NB00052","article-title":"Post-exposure prophylaxis for non-occupational exposure to HIV: Experience in NSW one year after the introduction of the guidelines","volume":"11","author":"Correll","year":"2000","journal-title":"NSW Public Health Bull"},{"key":"10.1157\/13128270_bb0065","unstructured":"CEESCAT. Informe final del Proyecto Europeo sobre Profilaxis Post-exposici\u00f3n no ocupacional al VIH (EURO-NONOPEP), Badalona, junio 2003. [Consultado el 4 mayo de 2007]. Disponible en: http:\/\/europa.eu.int\/comm\/health\/ph_projects\/2000\/com_diseases\/fp_commdis_2000_frep_26_en.pdf"},{"key":"10.1157\/13128270_bb0070","first-page":"433","article-title":"Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000","volume":"131","author":"Bernasconi","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1157\/13128270_bb0075","first-page":"173","article-title":"Evaluation de la prise en charge th\u00e9rapeutique des expositions au VIH, juillet 1999-d\u00e9cembre 2001","volume":"36","author":"Lot","year":"2002","journal-title":"Bull Epidemiol Hebdomadaire"},{"key":"10.1157\/13128270_bb0080","unstructured":"Puro V, Govoni A, Mattioli F, De Carli G, Ippolito G. Italian PEP Registry Antiretroviral post-exposure prophylaxis in Italy. XIII International AIDS Conference; Durban, South Africa, 9-14 July 2000. [Abstract WePeC4420]"},{"key":"10.1157\/13128270_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2807\/esm.09.06.00471-en","article-title":"Proposed recommendations for the management of HIV post-exposure prophylaxis alter sexual, injecting drug or other exposures in Europe","volume":"9","author":"Almeda","year":"2004","journal-title":"Euro Surveill"},{"key":"10.1157\/13128270_bb0090","first-page":"391","article-title":"Recomendaciones para la profilaxis postexposici\u00f3n no ocupacional al VIH","volume":"20","author":"Grupo de consenso Espa\u00f1ol sobre profilaxis postexposici\u00f3n no ocupacional al VIH","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13128270_bb0095","first-page":"35","article-title":"Prophylaxie antir\u00e9trovirale apr\u00e8s une exposition non professionnelle au VIH en Provence-Alpes-C\u00f4te d\u2019Azur, 2001 et 2002","volume":"4","author":"Villes","year":"2006","journal-title":"Bull Epidemiol Hebdomadaire"},{"key":"10.1157\/13128270_bb0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bmj.330.7495.825","article-title":"Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3","volume":"330","author":"Sonder","year":"2005","journal-title":"BMJ"},{"key":"10.1157\/13128270_bb0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/318829","article-title":"Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP study","volume":"183","author":"Kahn","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1157\/13128270_bb0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.olq.0000237838.43716.ee","article-title":"Trends in HIV Postexposure Prophylaxis Prescription and Compliance After Sexual Exposure in Amsterdam, 2000-2004","volume":"34","author":"Sonder","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1157\/13128270_bb0115","first-page":"105","article-title":"Profilaxis post-exposici\u00f3n no ocupacional al virus de la inmunodeficiencia humana: \u00bfespada de dos filos? Editorial","volume":"18","author":"Pe\u00f1a","year":"2000","journal-title":"Enf Infecc Microbiol Clin"},{"key":"10.1157\/13128270_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00002030-200202150-00011","article-title":"Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians\u2019 experiences and attitudes","volume":"16","author":"Laporte","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13128270_bb0125","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00002030-200205030-00014","article-title":"Prescribing practices in a population-based HIV postexposure prophylaxis program","volume":"16","author":"Braitstein","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13128270_bb0130","first-page":"338","article-title":"Emergency prophylaxis following leedle-stick injuries and sexual exposures: results from a survey comparing New Cork Emergency Department practicioners with their national colleagues","volume":"70","author":"Merchant","year":"2003","journal-title":"Mt Sinai J Med"},{"key":"10.1157\/13128270_bb0135","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1157\/13128270_bb0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/422459","article-title":"Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV","volume":"39","author":"Bassett","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128270_bb0145","first-page":"238","article-title":"Short term adverse effects from and discontinuation of antiretroviral postexposure prophylaxis","volume":"15","author":"Puro","year":"2001","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1157\/13128270_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/426589","article-title":"Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection","volume":"40","author":"Rabaud","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128270_bb0155","first-page":"395","article-title":"Italian Registry of Antiretroviral Post-Exposure Prophylaxis Postexposure HIV prophylaxis regimen","volume":"39","author":"Puro","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128270_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/135965350200700309","article-title":"Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxis","volume":"7","author":"Garc\u00eda","year":"2002","journal-title":"Antivir Ther"},{"key":"10.1157\/13128270_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1071\/NB00052","article-title":"Post-exposure prophylaxis for non-occupational exposure to HIV: experience in NSW one year after the introduction of the guidelines","volume":"11","author":"Correll","year":"2000","journal-title":"NSW Public Health Bull"},{"key":"10.1157\/13128270_bb0170","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/497268","article-title":"Seroconversion Following Nonoccupational Postexposure Prophylaxis against HIV","volume":"41","author":"Roland","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08752595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08752595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T12:04:55Z","timestamp":1684843495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X08752595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0213005X08752595"],"URL":"https:\/\/doi.org\/10.1157\/13128270","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}